Jose F. Caro

José F. Caro (born Granada, Spain, 1948) is an American physician, scientist, and educator most notable for his research in obesity and diabetes.

The Institute for Scientific Information listed him the third most cited investigator in the world in the field of obesity research during the 1991-2000 period for his work on Leptin.

[8][9][10] Caro was the founding Director of the Division of Endocrinology and Metabolism of The Brody School of Medicine at East Carolina University (ECU) (1982-1991).

[11] Also, in collaboration with Walter Pories, that gastric bypass surgery induced a long lasting remission of the disease in about 80% of obese people with diabetes.

[13] At the time of such work the gastric bypass surgery was an experimental procedure, which is now well accepted in standard clinical practice.

For the sum of this work Caro was elected a member of The American Society for Clinical Investigation (Young Turk).

[22] In 1996 Caro was named Vice President of Endocrine Research and Clinical Investigation and global diabetes care at Eli Lilly & comp.

[25][26] During Caro´s tenure the endocrine portfolio of Lilly products grew from insulin and Humatrope to include Byetta, Actos, Evista and Forteo.

[8] For the sum of his work Caro was elected Miembro Honorario of the Real Academia de Medicina of Granada, Spain.